A combination of aromatic 3-Methylcholanthrene and AHR inhibits the proliferation and differentiation of osteocytes, suggesting that the active components of the drug might be involved in the occurrence and development of PCOS ad PMO through AHR (Naruse et al., 2002). This evidence concerns the gene AHR and polycystic ovary syndrome.